Sykehuset i Vestfold

Running trials

• Not yet recruiting

  Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion in Participants With Relapsed or Refractory Multiple Myeloma.

  NCT07757412· Phase 2· Odense University Hospital· Source

• Recruiting

  ARTEMIS - The ARTEMIS Cohort

  NCT07421219· Vastra Gotaland Region· Source

• Recruiting

  Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

  NCT07106762· Phase 2/3· Bristol-Myers Squibb· Source

• Recruiting

  Comprehensive Evaluation of Two Second-Line Therapeutic Approaches for Immune Thrombocytopenia (ITP) – a Pragmatic Randomized Controlled Trial - Holistic Study

  2023-505573-32-00· Phase 3· Ostfold Hospital Trust· Source

• Recruiting

  Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer

  NCT06781879· Phase 4· Jakob Kristian Jakobsen· Source

• Recruiting

  Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.

  NCT06626022· Phase 3· University of Alberta· Source

• Recruiting

  eHealth Based treatment of AdolescenT obesiTy with Low energy diet and sEmaglutide (eBATTLE Obesity)

  2023-506289-29-00· Phase 4· Vestfold Hospital Trust· Source

• Recruiting

  The Norwegian Immunotherapy in Multiple Myeloma Study

  NCT06855121· St. Olavs Hospital· Source

• Recruiting

  MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

  NCT06152575· Phase 3· Pfizer· Source

• Recruiting

  A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials

  NCT06285318· Janssen-Cilag Ltd.· Source

• Active, not recruiting

  Remote Monitoring After Heart Failure

  NCT05447598· Vestre Viken Hospital Trust· Source

• Recruiting

  Laparoscopic Single Anastomosis Sleeve Ileal Bypass Versus Laparoscopic Sleeve Gastrectomy for Morbid Obesity

  NCT05611697· Oslo University Hospital· Source

• Recruiting

  SACK

  2022-501600-10-00· Phase 3· Karolinska University Hospital· Source

• Recruiting

  Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer

  NCT05448547· Phase 3· Sven Löffeler· Source

• Recruiting

  Active Surveillance Plus (AS+): High-intensity Focused Ultrasound (HIFU) in Patients With Localized Prostate Cancer

  NCT04549688· The Hospital of Vestfold· Source

• Recruiting

  A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma

  NCT04332822· Phase 3· Nordic Lymphoma Group· Source

• Recruiting

  Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial

  NCT03977571· Niels Fristrup· Source

• Active, not recruiting

  BladMetrix Urine Test for Monitoring Recurrence in Non-Muscle Invasive Bladder Cancer

  NCT07511517· Oslo University Hospital· Source

• Recruiting

  Genetic Study of Amyotrophic Lateral Sclerosis in Norway

  NCT05119387· Sykehuset Telemark· Source

• Active, not recruiting

  Prevention of Coronary Heart Disease in Morbidly Obese Patients

  NCT00626964· The Hospital of Vestfold· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Multiple myeloma4 recruiting
• Prostate cancer3 recruiting
• Bladder cancer2 recruiting
• Obesity2 recruiting
• ALS (motor neurone disease)1 recruiting
• Amyloidosis1 recruiting
• Atrial fibrillation1 recruiting
• Cerebral palsy1 recruiting
• Chronic kidney disease1 recruiting
• Immune thrombocytopenia (ITP)1 recruiting
• Kidney cancer1 recruiting

Closed trials

• Completed

  A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

  NCT06077864· Phase 3· Boehringer Ingelheim· Source

• Completed

  Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).

  NCT05742802· Phase 3· AstraZeneca· Source

• Completed

  The Nordic IBD Treatment Strategy Trial

  NCT05180175· Phase 4· Region Örebro County· Source

• Completed

  NORDTREAT Prospective Study on Inflammatory Bowel Disease

  NCT05414578· University of Southern Denmark· Source

• Completed

  Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations

  NCT05166889· Phase 3· AstraZeneca· Source

• Completed

  The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study

  NCT04122235· Sorlandet Hospital HF· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Cerebral palsy8 works · 1 trial
• Down syndrome7 works · 0 trials